Effect of Infant Formulas Containing a New Fat Blend or the New Fat Blend Plus Fiber in Healthy Term Infants
9055A1-2000
Effect of an Infant Formula With High 2-Palmitic Vegetable Oil or an Identical Formula Supplemented With Oligofructose on Stool Composition and Stool Characteristics in Healthy Term Infants in Taiwan
1 other identifier
interventional
220
1 country
4
Brief Summary
- The primary objective of the study was to compare stool composition (stool soap and non-soap fatty acids, total fatty acids, minerals, and other stool constituents) of infants randomized to receive either standard formula, or 1 of 2 innovative formulas containing a new fat blend or the new fat blend plus fiber.
- The secondary objectives were to evaluate among the feeding groups, stool characteristics (stool consistency and frequency), GI tolerance assessed by the Infant Gastrointestinal Symptom Questionnaire (IGSQ), and urinary markers (F2-isoprostanes and 8-hydroxy-2'-deoxyguanosine \[8-OHdG\], and urine osmolality and specific gravity).
- The primary safety objective was to describe the frequency of adverse events (AEs) among the formula-fed (FF) groups.
- The secondary safety objective was to describe anthropometric measures (weight, length, and head circumference) among the feeding groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2010
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedFirst Submitted
Initial submission to the registry
December 23, 2013
CompletedFirst Posted
Study publicly available on registry
January 9, 2014
CompletedMarch 13, 2026
March 1, 2026
1.2 years
December 23, 2013
March 10, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Stool Composition
Stool soap and non-soap fatty acids, total fatty acids, minerals, and other stool constituents
Day 28
Secondary Outcomes (8)
Stool Consistency determined using a 3-day stool diary
Days 14 and 28
Stool frequency determined using a 3-day stool diary
Day 14 and 28
GI Tolerance
Baseline, Day 14 and Day 28
Incidence of adverse events
From ICF signing until 14 days after last study feeding
Anthropometric measurements
Baseline, Day 14 and Day 28
- +3 more secondary outcomes
Study Arms (4)
Control
OTHERStandard infant formula
Experimental 1
EXPERIMENTALStandard infant formula containing a new fat blend
Experimental 2
EXPERIMENTALStandard infant formula containing a new fat blend and fiber
Human Milk (HM)
NO INTERVENTIONNon-randomized Human Milk group
Interventions
Eligibility Criteria
You may qualify if:
- Healthy, term (no less than 37 weeks and no greater than 42 weeks) singleton infants; between 25 days to 45 days post natal age (date of birth = Day 0) and weight for age ≥3rd and ≤97th percentiles according to Taiwan growth charts at the time of study entry.
- Human milk fed infants were exclusively consuming and tolerating HM and the mother must have made the decision to continue to exclusively breastfeed.
- Formula-fed infants were exclusively consuming and tolerating a cow's milk infant formula and parents/LAR must have previously made the decision to continue to exclusively formula feed.
You may not qualify if:
- Infants receiving any amount of supplemental HM with infant formula feeding or vice versa
- Family history of siblings with documented cow's milk protein intolerance/allergy
- Major congenital malformations, suspected or documented systemic or congenital infections, evidence systemic diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Chang Gung Medical Foundation - LinKou Branch
Linkou District, Tao-Yuan County, Taiwan
Mackay Memorial Hospital - Hsinchu Branch
Hsinchu, Taiwan
Chang Gung Medical Foundation, Taipei Branch
Taipei, Taiwan
Mackay Memorial Hospital
Taipei, Taiwan
Related Publications (1)
Nowacki J, Lee HC, Lien R, Cheng SW, Li ST, Yao M, Northington R, Jan I, Mutungi G. Stool fatty acid soaps, stool consistency and gastrointestinal tolerance in term infants fed infant formulas containing high sn-2 palmitate with or without oligofructose: a double-blind, randomized clinical trial. Nutr J. 2014 Nov 5;13:105. doi: 10.1186/1475-2891-13-105.
PMID: 25373935DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 23, 2013
First Posted
January 9, 2014
Study Start
September 1, 2010
Primary Completion
December 1, 2011
Study Completion
December 1, 2011
Last Updated
March 13, 2026
Record last verified: 2026-03